LeMaitre Vascular Share Holder Equity 2010-2023 | LMAT

LeMaitre Vascular share holder equity from 2010 to 2023. Share holder equity can be defined as the sum of preferred and common equity items
LeMaitre Vascular Annual Share Holder Equity
(Millions of US $)
2023 $298
2022 $268
2021 $254
2020 $173
2019 $148
2018 $130
2017 $110
2016 $88
2015 $78
2014 $68
2013 $57
2012 $53
2011 $52
2010 $52
2009 $48
LeMaitre Vascular Quarterly Share Holder Equity
(Millions of US $)
2023-12-31 $298
2023-09-30 $289
2023-06-30 $284
2023-03-31 $274
2022-12-31 $268
2022-09-30 $261
2022-06-30 $258
2022-03-31 $258
2021-12-31 $254
2021-09-30 $249
2021-06-30 $186
2021-03-31 $178
2020-12-31 $173
2020-09-30 $161
2020-06-30 $153
2020-03-31 $149
2019-12-31 $148
2019-09-30 $142
2019-06-30 $138
2019-03-31 $133
2018-12-31 $130
2018-09-30 $125
2018-06-30 $121
2018-03-31 $113
2017-12-31 $110
2017-09-30 $106
2017-06-30 $98
2017-03-31 $92
2016-12-31 $88
2016-09-30 $87
2016-06-30 $83
2016-03-31 $81
2015-12-31 $78
2015-09-30 $74
2015-06-30 $70
2015-03-31 $68
2014-12-31 $68
2014-09-30 $67
2014-06-30 $68
2014-03-31 $56
2013-12-31 $57
2013-09-30 $55
2013-06-30 $54
2013-03-31 $53
2012-12-31 $53
2012-09-30 $52
2012-06-30 $52
2012-03-31 $52
2011-12-31 $52
2011-09-30 $53
2011-06-30 $53
2011-03-31 $52
2010-12-31 $52
2010-09-30 $51
2010-06-30 $49
2010-03-31 $49
2009-12-31 $48
2009-09-30 $47
2009-06-30 $46
2009-03-31 $44
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.442B $0.193B
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $186.688B 24.51
Stryker (SYK) United States $127.423B 31.59
Medtronic (MDT) Ireland $107.939B 15.28
Boston Scientific (BSX) United States $101.215B 33.65
EssilorLuxottica (ESLOY) France $99.656B 0.00
Lonza Group Ag (LZAGY) Switzerland $42.872B 0.00
Haleon (HLN) United Kingdom $38.401B 30.04
ResMed (RMD) United States $27.097B 27.09
Terumo (TRUMY) Japan $25.416B 35.90
Zimmer Biomet Holdings (ZBH) United States $24.968B 16.07
Baxter (BAX) United States $20.831B 15.19
Koninklijke Philips (PHG) Netherlands $19.511B 15.56
Insulet (PODD) United States $11.713B 61.50
Smith & Nephew SNATS (SNN) United Kingdom $10.842B 0.00
Demant (WILYY) Denmark $9.943B 0.00
Bio-Rad Laboratories (BIO) United States $8.136B 24.24
BellRing Brands (BRBR) United States $7.357B 39.56
Lantheus Holdings (LNTH) United States $4.415B 11.40
Haemonetics (HAE) United States $4.320B 22.10
Perrigo (PRGO) Ireland $4.132B 11.82
GN Store Nord (GNNDY) Denmark $3.937B 25.50
Prestige Consumer Healthcare (PBH) United States $3.536B 16.72
Envista Holdings (NVST) United States $3.475B 13.22
QuidelOrtho (QDEL) United States $2.702B 9.81
Neogen (NEOG) United States $2.666B 25.65
Green Thumb Industries (GTBIF) United States $2.566B 81.33
ICU Medical (ICUI) United States $2.382B 17.77
TG Therapeutics (TGTX) United States $2.202B 712.50
Owens & Minor (OMI) United States $1.959B 18.80
Maravai LifeSciences Holdings (MRVI) United States $1.941B 0.00
Agios Pharmaceuticals (AGIO) United States $1.788B 0.00
Verano Holdings (VRNOF) United States $1.662B 0.00
National Vision Holdings (EYE) United States $1.475B 45.95
InMode (INMD) Israel $1.459B 7.55
Warby Parker (WRBY) United States $1.318B 0.00
AdaptHealth (AHCO) United States $1.304B 9.81
AtriCure (ATRC) United States $1.121B 0.00
MacroGenics (MGNX) United States $1.015B 0.00
Canopy Growth (CGC) Canada $0.905B 0.00
BioLife Solutions (BLFS) United States $0.771B 0.00
VAREX IMAGING (VREX) United States $0.701B 15.15
Cresco Labs (CRLBF) United States $0.695B 0.00
Evolus (EOLS) United States $0.678B 0.00
Quanterix (QTRX) United States $0.616B 0.00
Phibro Animal Health (PAHC) United States $0.551B 11.94
Jin Medical (ZJYL) China $0.543B 0.00
Valneva SE (VALN) France $0.539B 0.00
TerrAscend (TSNDF) Canada $0.492B 0.00
PetIQ (PETQ) United States $0.489B 18.24
ZimVie (ZIMV) United States $0.437B 26.75
OraSure Technologies (OSUR) United States $0.423B 7.00
Biote (BTMD) United States $0.415B 3.95
Aurora Cannabis (ACB) Canada $0.405B 0.00
Surmodics (SRDX) United States $0.383B 41.42
Zynex (ZYXI) United States $0.362B 41.70
Viemed Healthcare (VMD) United States $0.312B 31.00
Cerus (CERS) United States $0.305B 0.00
Sanara MedTech (SMTI) United States $0.281B 0.00
TriSalus Life Sciences (TLSI) United States $0.273B 0.00
Utah Medical Products (UTMD) United States $0.242B 14.78
Organigram Holdings (OGI) Canada $0.201B 0.00
Ayr Wellness (AYRWF) United States $0.191B 0.00
Veru (VERU) United States $0.187B 0.00
Omeros (OMER) United States $0.179B 0.00
High Tide (HITI) Canada $0.170B 0.00
Quipt Home Medical (QIPT) United States $0.164B 0.00
Capricor Therapeutics (CAPR) United States $0.152B 0.00
Jushi Holdings (JUSHF) United States $0.133B 0.00
Eagleford Energy (GRUSF) United States $0.132B 66.41
FitLife Brands (FTLF) United States $0.129B 20.70
InterCure (INCR) Israel $0.118B 20.00
Fonar (FONR) United States $0.101B 8.70
Cellectar Biosciences (CLRB) United States $0.100B 0.00
MariMed (MRMD) United States $0.096B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.095B 0.00
Allurion Technologies (ALUR) United States $0.086B 0.00
Chimerix (CMRX) United States $0.083B 0.00
Brainsway (BWAY) Israel $0.082B 0.00
Safety Shot (SHOT) United States $0.080B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.062B 4.04
Zevia PBC (ZVIA) United States $0.061B 0.00
Cytosorbents (CTSO) United States $0.048B 0.00
Apyx Medical (APYX) United States $0.046B 0.00
Rockwell Medical (RMTI) United States $0.045B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Bright Green (BGXX) United States $0.038B 0.00
United-Guardian (UG) United States $0.037B 14.54
Modular Medical (MODD) United States $0.034B 0.00
Exagen (XGN) United States $0.024B 0.00
Nephros (NEPH) United States $0.023B 0.00
GlucoTrack (GCTK) United States $0.020B 0.00
Agape ATP (ATPC) $0.019B 0.00
Flora Growth (FLGC) United States $0.019B 0.00
FSD PHARMA (HUGE) Canada $0.018B 0.00
Meihua Medical Technologies (MHUA) China $0.017B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
GUARDION HEALTH (GHSI) United States $0.011B 75.27
NeuroMetrix (NURO) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.008B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Senestech (SNES) United States $0.004B 0.00
Innovative Eyewear (LUCY) United States $0.003B 0.00
Lucy Scientific Discovery (LSDI) Canada $0.002B 0.00
Akanda (AKAN) United Kingdom $0.001B 0.00
Smart For Life (SMFL) United States $0.001B 0.00
Bruush Oral Care (BRSH) $0.000B 0.00
SNDL (SNDL) Canada $0.000B 0.00